Peter Michael Smith;Andrew Derek Sutton;Anthony Ian Walker;Angus George Dalgleish
发明人:
Angus George Dalgleish,Peter Michael Smith,Andrew Derek Sutton,Anthony Ian Walker
申请号：
US13270820
公开号：
US20120164099A1
申请日:
2011.10.11
申请国别(地区):
US
年份:
2012
代理人:
摘要：
This invention is concerned with agents for the treatment of primary, metastatic and residual cancer in mammals (including humans) by inducing the immune system of the mammal or human afflicted with cancer to mount an attack against the tumour lesion. In particular, the invention pertains to the use of whole-cells, derivatives and portions thereof with or without vaccine adjuvants and/or other accessory factors. More particularly, this disclosure describes the use of particular combinations of whole-cells and derivatives and portions thereof that form the basis of treatment strategy.
